VTCN1 and pancreatic adenocarcinoma: Single B7-H3 or B7-H4 expression exhibits limited prognostic value for assessment of clinical outcome in PAAD, while combined their expression is a promising stratification strategy to evaluate prognosis and immunogenicity in PAAD.